Standardpharm

Standard Chem & Pharm is a leading Taiwanese pharmaceutical company specializing in the development, manufacturing, and marketing of generic drugs and active pharmaceutical ingredients (APIs). Founded in 1967, the company operates multiple PIC/S GMP-certified facilities and offers a broad portfolio of products across various therapeutic areas, including cardiovascular, metabolic, and central nervous system disorders. In addition to its own product line, Standard Chem & Pharm provides contract development and manufacturing services (CDMO) to global partners. The company is publicly traded on the Taiwan Stock Exchange and maintains a significant presence in both domestic and international markets. Their capabilities include the production of solid dosages, injectables, and specialized API synthesis. Standard Chem & Pharm is recognized for its commitment to quality and has successfully passed inspections by the US FDA and other international regulatory bodies.